TE_102
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | SVA_D |
|---|---|
| TE superfamily | SVA |
| TE class | Retroposon |
| Gene | ENSG00000284735 |
| Class | Chimeric |
| Coding | Non-coding |
| Tumor-specific score | 1.69 |
| Counts of samples | TCGA_tumor:2; TCGA_normal:0; GTEx:1 |
| TSS | chr1(-):10390499 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_102.1 | ENSG00000284735 | Chimeric | Non-coding | Non-coding | chr1(-):10381981,10382001,10386239,10389898,10390411,10390500 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
